BetterLife Pharma Statistics

Total Valuation

BetterLife Pharma has a market cap or net worth of CAD 14.03 million. The enterprise value is 18.41 million.

Market Cap	14.03M
Enterprise Value	18.41M

Important Dates

The next estimated earnings date is Thursday, December 26, 2024.

Earnings Date	Dec 26, 2024
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+20.64%
Shares Change (QoQ)	+3.93%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	93.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.77
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.07

Current Ratio	0.07
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.15

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-707.53%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-697,751
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +75.00% in the last 52 weeks. The beta is 1.42, so BetterLife Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	+75.00%
50-Day Moving Average	0.12
200-Day Moving Average	0.12
Relative Strength Index (RSI)	44.78
Average Volume (20 Days)	33,715

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-4.81M
Pretax Income	-4.40M
Net Income	-4.88M
EBITDA	n/a
EBIT	-4.81M
Earnings Per Share (EPS)	-0.04

Full Income Statement

Balance Sheet

The company has 126,305 in cash and 1.03 million in debt, giving a net cash position of -908,028.

Cash & Cash Equivalents	126,305
Total Debt	1.03M
Net Cash	-908,028
Net Cash Per Share	n/a
Equity (Book Value)	-7.57M
Book Value Per Share	-0.08
Working Capital	-5.81M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.51M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BetterLife Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.64%
Shareholder Yield	-20.64%
Earnings Yield	-40.08%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a